Sign in
4

Changes in Ownership

Bausch Health Companies Inc. Filed Acc 0001127602-22-008251

U.S. President-Pharma Business sold 1,595 shares at $23.37 ($37,275)

  • U.S. President-Pharma Business acquired 35,627 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Spurr Robert U.S. President-Pharma Business 2022-03-02 Sale −1,595 $23.37 $37,275 65,394 D
Spurr Robert U.S. President-Pharma Business 2022-03-02 Grant or award +35,627 $24.17 $861,105 101,021 D
Derivatives
Spurr Robert U.S. President-Pharma Business 2022-03-02 Grant or award · Non-Qualified Stock Options (right to purchase) +131,910 131,910 D
Open-market sales · 1,595 sh · avg $23.37 · $37,275
Loading xslF345X03/form4.xml…